OR WAIT null SECS
January 25, 2023
Expansion expected to help tackle health issues at a faster rate, company says
Annual report finds continuing impact of COVID-19 on global markets
January 16, 2023
Partnership aims to lower prescription drug costs and increase price transparency
January 13, 2023
Dr. Liz Kwo of Everly Health outlines 2023 predictions for AI, including how it can be beneficial to patients
January 05, 2023
Provider’s regulatory affairs, pharmacovigilance services expected to help increase ABC’s portfolio
January 02, 2023
A Q&A with AstraZeneca’s Country President for Belgium & Luxembourg, Keira Driansky
December 16, 2022
Dr. Troy Sarich of Janssen reveals the company's approach to tackling financial challenges as they pertain to tech
Purchase strengthens Amgen’s therapeutics portfolio
November 18, 2022
Drug safety analysis to be conducted at Rockland, MD facility
November 17, 2022
A Harvard Business School Healthcare Alumni Association C-suite Q&A with Mark Cuban, Cost Plus Drugs co-founder